Latest Breaking News On - Randalw scott - Page 2 : comparemela.com

BridgeBio Pharma (NASDAQ:BBIO) PT Lowered to $43 00

BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) had its target price reduced by research analysts at HC Wainwright from $47.00 to $43.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s target price indicates a potential upside of 46.86% from the […]

Bio pharmaRaymond jamesBridgebio pharmaRandalw scottBridgebio pharma incInvestment advisors incHealthcare of ontario pension plan trust fundEntrypoint capitalCantor fitzgeraldAssetmark incGet free reportBio pharma trading downDirector randalPoint capitalOntario pension plan trust fundBridgebio pharma daily

BridgeBio Pharma, Inc (NASDAQ:BBIO) Sees Large Growth in Short Interest

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) saw a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 16,230,000 shares, a growth of 7.7% from the April 15th total of 15,070,000 shares. Currently, 11.5% of the company’s stock are sold short. Based on an […]

United statesBridgebio pharmaRandalw scottRaymond jamesBio pharmaBridgebio pharma incSecurities exchange commissionPricet rowe associates incComerica bankJpmorgan chase coJanus henderson groupGet free reportBio pharma trading downDirector randalExchange commissionState teachers retirement system

BridgeBio Pharma (NASDAQ:BBIO) Upgraded to Strong-Buy by Evercore ISI

BridgeBio Pharma (NASDAQ:BBIO) Upgraded to Strong-Buy by Evercore ISI
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Bridgebio pharmaRandalw scottRaymond jamesBio pharmaAssetmark incEntrypoint capitalHealthcare of ontario pension plan trust fundInvestment advisors incBridgebio pharma incGet free reportDirector randalPoint capitalOntario pension plan trust fundBridgebio pharma daily

Brokerages Set BridgeBio Pharma, Inc (NASDAQ:BBIO) Target Price at $47 82

Brokerages Set BridgeBio Pharma, Inc (NASDAQ:BBIO) Target Price at $47 82
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Bio pharmaBridgebio pharmaRandalw scottRaymond jamesCampbell co investment adviserMoody aldrich partnersManufacturers life insurance companyJpmorgan chase coPrimecap management coCantor fitzgeraldBridgebio pharma company profileBridgebio pharma incBoone capital managementBio pharma incGet free reportDirector randal

Certuity LLC Invests $258,000 in BridgeBio Pharma, Inc (NASDAQ:BBIO)

Certuity LLC Invests $258,000 in BridgeBio Pharma, Inc (NASDAQ:BBIO)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandRandalw scottBio pharmaBridgebio pharma incLord abbettPrimecap management coSecurities exchange commissionExchange commissionNorthern trust corpCantor fitzgeraldCharles schwab investment management incBio pharma incWellington management groupBridgebio pharmaFree report